Dhruv Lowe1, Sheikh Saleem2, Muhammad Osman Arif2, Shreya Sinha3, Gary Brooks4. 1. Division of Gastroenterology and Hepatology, Department of Medicine, State University of New York, Upstate Medical University, Syracuse, NY, 13202, USA. dhruvlowe1@gmail.com. 2. Division of Gastroenterology and Hepatology, Department of Medicine, State University of New York, Upstate Medical University, Syracuse, NY, 13202, USA. 3. Division of Hematology and Oncology, Department of Medicine, State University of New York, Upstate Medical University, Syracuse, NY, 13202, USA. 4. Department of Public Health and Preventive Medicine, Center for Research and Evaluation, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
Abstract
BACKGROUND: Endoscopic resection (polypectomy) or surgery, are the main approaches in management of malignant colon polyps. There are very few large population-based studies comparing outcomes between the two. METHODS: Using the National Cancer Database, we identified patients ≥ 18 years with the first diagnosis of T1N0M0 malignant polyp from 2004 to 2015. Patients with a positive resection margin were excluded. Outcomes were compared between those who had surgery versus those who had polypectomy. Overall survival was compared using Kaplan-Meier curves. Multivariate Cox proportional hazards analysis was performed to generate hazard ratios, adjusted for patient, demographic, and tumor factors. RESULTS: A total of 31,062 patients met the inclusion criteria, out of which 2593 (8.3%) underwent polypectomy alone and 28,469 (91.7%) had surgery. Overall survival was significantly better in the surgical group compared with the polypectomy group. One-year and 5-year survival for surgery were 95.8% and 86.1% respectively compared with 94.2% and 80.6% for polypectomy (p < .0001). Hazard ratio for surgery after adjusting for various clinical-, demographic-, and tumor-level factors was 0.53 (p < .0001). CONCLUSION: Our study is the largest population-based analysis of patients with T1N0M0 malignant colon polyps. Overall survival was higher in patients who underwent surgery compared with polypectomy. This remained consistent even after adjusting for multiple patient and tumor factors between the two groups.
BACKGROUND: Endoscopic resection (polypectomy) or surgery, are the main approaches in management of malignant colon polyps. There are very few large population-based studies comparing outcomes between the two. METHODS: Using the National Cancer Database, we identified patients ≥ 18 years with the first diagnosis of T1N0M0 malignant polyp from 2004 to 2015. Patients with a positive resection margin were excluded. Outcomes were compared between those who had surgery versus those who had polypectomy. Overall survival was compared using Kaplan-Meier curves. Multivariate Cox proportional hazards analysis was performed to generate hazard ratios, adjusted for patient, demographic, and tumor factors. RESULTS: A total of 31,062 patients met the inclusion criteria, out of which 2593 (8.3%) underwent polypectomy alone and 28,469 (91.7%) had surgery. Overall survival was significantly better in the surgical group compared with the polypectomy group. One-year and 5-year survival for surgery were 95.8% and 86.1% respectively compared with 94.2% and 80.6% for polypectomy (p < .0001). Hazard ratio for surgery after adjusting for various clinical-, demographic-, and tumor-level factors was 0.53 (p < .0001). CONCLUSION: Our study is the largest population-based analysis of patients with T1N0M0 malignant colon polyps. Overall survival was higher in patients who underwent surgery compared with polypectomy. This remained consistent even after adjusting for multiple patient and tumor factors between the two groups.
Authors: K Reinhart; C Bannert; D Dunkler; P Salzl; M Trauner; F Renner; P Knoflach; A Ferlitsch; W Weiss; M Ferlitsch Journal: Endoscopy Date: 2013-04-24 Impact factor: 10.093
Authors: Jesse Fischer; Bruce Dobbs; Liane Dixon; Tim W Eglinton; Christopher J Wakeman; Frank A Frizelle Journal: ANZ J Surg Date: 2016-04-08 Impact factor: 1.872
Authors: Lars Boenicke; Martin Fein; Marco Sailer; Christoph Isbert; Christoph-Tomas Germer; Andreas Thalheimer Journal: Int J Colorectal Dis Date: 2009-11-06 Impact factor: 2.571
Authors: Andrew P Zammit; Nicholas J Lyons; Mark D Chatfield; John D Hooper; Ian Brown; David A Clark; Andrew D Riddell Journal: Int J Colorectal Dis Date: 2022-04-08 Impact factor: 2.796